Influence of 6-hydroxydopamine and of  -methyl-p-tyrosine on the effects of some centrally acting agents.
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001921:Brain / Q000187:drug effects; D001923:Brain Chemistry / Q000187:drug effects*; D002395:Catecholamines / Q000378:metabolism; D002415:Cats; D002746:Chlorpromazine / Q000494:pharmacology; D003042:Cocaine / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology*; D004336:Drug Antagonism; D005260:Female; D006799:Housing, Animal; D007267:Injections; D008297:Male; D008774:Methylphenidate / Q000494:pharmacology; D008781:Methyltyrosines / Q000494:pharmacology*; D051379:Mice; D009020:Morphine / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects
D002395:Catecholamines; D008781:Methyltyrosines; D008774:Methylphenidate; D009020:Morphine; D003042:Cocaine; D002746:Chlorpromazine; D004298:Dopamine